Daniel J. Lippis - Jan 1, 2024 Form 3 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, JAPAC
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Jan 1, 2024
Transactions value $
$0
Form type
3
Date filed
1/8/2024, 05:01 PM
Next filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EW Common Stock 17.8K Jan 1, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EW Employee Stock Option (Right to Acquire) Jan 1, 2024 Common Stock 3.43K $36.75 Direct
holding EW Employee Stock Option (Right to Acquire) Jan 1, 2024 Common Stock 5.57K $45.28 Direct
holding EW Employee Stock Option (Right to Acquire) Jan 1, 2024 Common Stock 7.13K $59.26 Direct
holding EW Employee Stock Option (Right to Acquire) Jan 1, 2024 Common Stock 6.81K $72.68 Direct
holding EW Employee Stock Option (Right to Acquire) Jan 1, 2024 Common Stock 6.32K $88.78 Direct
holding EW Employee Stock Option (Right to Acquire) Jan 1, 2024 Common Stock 5.44K $93.31 Direct
holding EW Employee Stock Option (Right to Acquire) Jan 1, 2024 Common Stock 4.87K $105.93 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24, Power of Attorney, attached.